Comparer des méthodes

	Évaluation Cognitive de Montréal	Évaluation clinique de la démence
Domaine	Réadaptation	Réadaptation
Famille	Process / pipeline	Process / pipeline
Année d'origine	2005	1984
Auteur d'origine	Nasreddine, Phillips, Bédirian	Morris, John C.
Type	Cognitive screening test	Clinician-rated scale
Source fondatrice	Nasreddine, Z. S., Phillips, N. A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., ... & Chertkow, H. (2005). The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society, 53(4), 695–699.	Morris, J. C. (1993). The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology, 43(11), 2412–2414.
Alias	MoCA, MoCA Test, Montreal Cognitive Assessment Test	CDR, CDR Scale, Washington University Dementia Rating
Apparentées	1	1
Résumé	The Montreal Cognitive Assessment (MoCA) is a brief 10-minute cognitive screening test designed to detect mild cognitive impairment (MCI) in older adults. Developed by Nasreddine and colleagues in 2005 at McGill University, MoCA is more sensitive to cognitive impairment than the Mini-Cog or MMSE, particularly for detecting early Alzheimer's disease and non-Alzheimer dementias, making it widely used in primary care, neurology, and geriatric medicine.	The Clinical Dementia Rating (CDR) is a clinician-administered scale that assesses severity of dementia on a 0–3 scale based on interview with the patient and an informed collateral source (e.g., family member). Developed by Morris and colleagues at Washington University School of Medicine, the CDR has become the reference standard for dementia severity assessment in clinical practice and research, particularly for staging Alzheimer's disease.